CVS Health Corporation (CVS)
Coverage summary
Aardvark Labs Capital Research has covered CVS Health Corporation (CVS) since May 7, 2026. The company is in the Healthcare sector. This page lists 3 reports: 3 earnings recaps.
The latest is the Q3 2026 Earnings Recap, published November 5, 2026. That report moved the rating from Hold to Outperform. The rating has changed once since coverage began.
Translations: 2 in Chinese.
Rating history
All CVS reports
2026-11-05
Recap: Q3 2026
The Quarter Cleared Both Our Upgrade Triggers and the Stock Fell 12.5% on a Breakup Nobody Priced
2026-08-06
Recap: Q2 2026
All Three Operating Segments Grew and the Stock Still Fell 5%: 2027 Is the Real Disclosure
2026-05-07
Recap: Q1 2026
Aetna Carries the Whole Enterprise; the Raise Is a Reserve Release, Not a Trend Call